1ZTS:BIT
Zoetis Inc
61,60 €
arrow_downward
-0,93%(-0,58) 1D
2-окт., 17:26:00 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
News stories
From web sources and news partners
ad-hoc-news.de
·
1 саат мурун
Zoetis appoints Iris Knobloch to board as Zoetis stock holds value
The Globe and Mail
·
8 саат мурун
3 Reasons ZTS is Risky and 1 Stock to Buy Instead
Simply Wall Street
·
1 күн мурун
Zoetis (ZTS) Stock May Sit Below Fair Value After Mixed Q2 Results
Kalkine Media
·
1 күн мурун
Zoetis EVP Rimma Driscoll Acquires 277.77 Phantom Stock Units via Supplemental Savings Plan
Profile
Zoetis Inc., headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries.
In 2025, 70% of the company's revenue came from products for pets and 29% of the company's revenues came from products for livestock. In 2025, 54% of the company's revenue came from customers in the United States. Of this revenue, 79% came from products for dogs and cats, 13% came from products for cattle, and 4% came from products for horses. In 2025, 46% of the company's revenue came from international customers. Of this revenue, 53% came from products for dogs and cats, 19% came from products for cattle, 9% came from products for swine, 7% came from products for poultry, and 3% came from products for horses. Wikipedia